Understanding challenges and barriers to quality end-of-life care for patients with hematologic malignancies: a GIMEMA survey.

ABSTRACT: Patients with hematologic malignancies often receive aggressive end-of-life (EOL) care, which may be partly related to hematologists' discomfort with discontinuing aggressive treatments at EOL. It is therefore important to investigate how hematologists perceive EOL care and how this affects their clinical practice. We assessed a cohort of Italian hematological oncologists through a GIMEMA online survey to explore their attitudes toward standard measures of quality EOL care, their opinions on barriers to providing this care, and potential interventions. EOL quality measures were defined acceptable to hematologist if at least 55% of respondents agreed with their suitability. One-hundred eight-six hematologists completed the survey. Hematologists rated 8 of 13 EOL quality measures as highly a

SUBMITTER: Potenza L 

PROVIDER: S-EPMC12619704 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature